Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Customer Support
Subscribe
Reports
Agribusiness Consulting
Advertise
UsernamePublicRestriction
Tags:
Canine Cancer Pharmaceuticals

Vetco canine cancer drug begins to emerge as viable competitor with surgery

  • Interviews

In the fourth quarter of 2017, Taiwanese firm Vetco launched its Antican drug for the treatment of canine perianal gland tumors. Two years later, the company is starting to take a share in its local market, Vetco's international business development manager Suet Ling Teh told Animal Pharm editor Joseph Harvey.

Table

View full table

Topics

What to read next

Tags:
Canine Cancer Pharmaceuticals
UsernamePublicRestriction

Register

AP016423

Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By